After 12 years of experience in my previous role as Publisher at the Future Science Group, where I launched and managed a portfolio of 50+ journals including the Medline-indexed Regenerative Medicine (Impact Factor 3.52) and Nanomedicine (IF: 5.82), I founded BioInsights with the vision of publishing high-quality research and commentary in areas of bioscience that offer true potential to revolutionize modern healthcare. Over the years I have developed specialist knowledge in the fields of stem cell research, pharmacogenomics and vaccinology, and have been responsible for the conception, launch and development of several key journal titles that are now widely respected in these areas, including Regenerative Medicine (recipient of the ALPSP ‘Best New Journal’ award in 2006.
Nicola has been working in the life sciences sector for 21 years. She founded Phacilitate, a specialist pharma and biotech conference organiser, in 2001 selling the business 11 years later. She launched the Cell & Gene Therapy Forum in 2005 and ran the meeting for 8 years. Her main responsibilities were content development, commercial planning, business development and marketing.
Nicola has extensive experience across multiple therapeutic areas, and has wide knowledge of the issues faced at all stages of the drug development pipeline.